Der Hautarzt (HAUTARZT)

Publisher: Deutsche Dermatologische Gesellschaft, Springer Verlag

Journal description

Der Hautarzt ist als Organ der Deutschen Dermatologischen Gesellschaft eine international angesehene Zeitschrift und informiert regelmäßig alle in Klinik und Praxis tätigen Dermatologen über wichtige Entwicklungen in der gesamten Dermatologie einschließlich Allergologie Venerologie und ihrer verwandten Gebiete. In Originalarbeiten werden wichtige klinisch relevante Studien und Forschungsergebnisse veröffentlicht. Kritisch und kompetent widmet sich der Aktuelle Kommentar einer im Brennpunkt stehenden Fragestellung. Die Übersicht führt den Leser in ein zentrales Thema seines klinischen Alltags ein und gibt den Überblick über den state of the art. In den Farbbildkasuistiken zeigen Fallbeispiele Wege der rationalen Diagnostik und Entscheidungsfindung. In der Rubrik Weiterbildung wird dem Assistenzarzt in Weiterbildung zum Facharzt didaktisch aufgearbeiteter Wissensstoff und dem Niedergelassenen ein optimiertes Repetitorium vermittelt. In den Gelben Seiten informiert die DDG regelmäßig über die Aktivitäten der Arbeitsgemeinschaften und des Vorstands Fakten zur Gesundheitspolitik und Kongreßaktivitäten. Die Anfragen aus der Praxis spiegeln den Dialog der Leser mit ihrer Facharztzeitschrift wider. In Gehört - Gelesen - Nachgefragt wird über aktuelle Themen von grundsätzlicher medizinischer bzw. interdisziplinärer Bedeutung berichtet. Zur Publikation eingereichte Manuskripte müssen bei Untersuchungen an Probanden oder Patienten die Erklärung enthalten daß das Versuchsprotokoll von einer Ethikkommission begutachtet wurde und somit den ethischen Standards der Deklaration von Helsinki 1964 in der jeweils gültigen Fassung (Pharm. Ind. Nr. 12/1990 sowie Bundesanzeiger Nr. 243a vom 29. 12. 1989) entspricht. Gleichzeitig ist - gegebenenfalls - die Einwilligung des Patienten nach Aufklärung im Text des Manuskriptes zu fixieren. Hinweise die auf die Identität schließen lassen sind zu vermeiden. Tierversuchsprogramme müssen den Passus enthalten daß die "Principles of laboratory animal care" (NIH publication No. 86-23 revised 1985) eingehalten wurden soweit nicht zusätzlich besondere nationale Regelungen zu beachten sind (für die Bundesrepublik Deutschland ist dies das Tierschutzgesetz in aktueller Fassung). Die Schriftleitung behält sich deshalb das Recht vor Manuskripte abzulehnen die den o.g. Anforderungen nicht entsprechen. Der Autor haftet bei Verstoß gegen die o.g. Anforderungen oder bei falschen Angaben.

Current impact factor: 0.54

Impact Factor Rankings

2015 Impact Factor Available summer 2015
2013 / 2014 Impact Factor 0.543
2012 Impact Factor 0.504
2011 Impact Factor 0.576
2010 Impact Factor 0.451
2009 Impact Factor 0.434
2008 Impact Factor 0.362
2007 Impact Factor 0.333
2006 Impact Factor 0.498
2005 Impact Factor 0.535
2004 Impact Factor 0.461
2003 Impact Factor 0.521
2002 Impact Factor 0.426
2001 Impact Factor 0.612
2000 Impact Factor 0.535
1999 Impact Factor 0.552
1998 Impact Factor 0.479
1997 Impact Factor 0.487
1996 Impact Factor 0.422
1995 Impact Factor 0.314
1994 Impact Factor 0.397
1993 Impact Factor 0.321
1992 Impact Factor 0.314

Impact factor over time

Impact factor
Year

Additional details

5-year impact 0.40
Cited half-life 0.00
Immediacy index 0.13
Eigenfactor 0.00
Article influence 0.09
Website Hautarzt, Der website
Other titles Hautarzt (Online)
ISSN 0017-8470
OCLC 42959962
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

Springer Verlag

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Author's pre-print on pre-print servers such as arXiv.org
    • Author's post-print on author's personal website immediately
    • Author's post-print on any open access repository after 12 months after publication
    • Publisher's version/PDF cannot be used
    • Published source must be acknowledged
    • Must link to publisher version
    • Set phrase to accompany link to published version (see policy)
    • Articles in some journals can be made Open Access on payment of additional charge
  • Classification
    ​ green

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: AnamneseEine 51-jährige Patientin wurde im Oktober 2014 wegen eines langsam wachsenden Tumors in der linken Axilla in unserer Ambulanz vorstellig. Beschwerden gab die Patientin nicht an, die Lymphknoten waren palpatorisch unauffällig.HautbefundIn der linken Axilla erkannte man eine ca. 0,3 × 0,3 cm große, scharf begrenzte, rötlich-orange-farbene, gläsern durchscheinende Papel von weicher Konsistenz (Abb. 1).Abb. 1Scharf begrenzte, rötlich-orangefarbene, gläserne PapelDermatoskopieEs fand sich eine rötlich-orangefarbene Papel ohne erkennbares Netzwerk. Im Zentrum der Läsion sah man einzelne zarte lineäre Gefäße (Abb. 2).Abb. 2Rötlich-orangefarbene Papel ohne erkennbares Netzwerk. Im Zentrum sind einzelne zarte lineäre Gefäße erkennbar. (Dermatoskopie mit Dermlite Foto 3gen, USA)Da mithilfe des klinischen und dermatoskopischen Befundes keine eindeutige Diagnose zu stellen war, entschieden wir uns für eine Totalexzision der Läsion.DiskussionDas adulte Xanthogranulom ist wesentlich seltene ...
    Der Hautarzt 05/2015; 66(5). DOI:10.1007/s00105-015-3615-z
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die rheumatoide neutrophile Dermatitis (RND) ist eine seltene Hauterkrankung und ist assoziiert mit einer schwer verlaufenden, seropositiven rheumatoiden Arthritis (RA). Sie tritt meist im mittleren Lebensalter auf. Am häufigsten treten erythematöse Papeln, Plaques und Noduli auf. Im Allgemeinen spricht die RND auf Glukokortikosteroide oder systemische Therapeutika der RA an. Hier präsentieren wir den Fall eines 70-jährigen Patienten mit RND und einer schweren rheumatoiden Arthritis, die auf die Kombination von systemischen Glukokortikosteroiden und Methotrexat ansprachen.
    Der Hautarzt 03/2015; 66(4). DOI:10.1007/s00105-015-3594-0
  • Der Hautarzt 03/2015; 66(3). DOI:10.1007/s00105-015-3606-0
  • [Show abstract] [Hide abstract]
    ABSTRACT: With the revision of the German Ordinance on Occupational Diseases, skin cancer due to UV irradiation was amended as a new occupational disease to the list of occupational diseases in Germany. The new occupational disease BK 5103 has the following wording: "Squamous cell carcinoma or multiple actinic keratosis of the skin caused by natural UV irradiation". Actinic keratoses are to be considered as multiple according to this new occupational diseases if they occur as single lesions of more than five annually, or are confluent in an area > 4 cm(2) (field cancerization). It is estimated that more than 2.5 million employees are exposed to natural UV irradiation due to their work (outdoor workers) in Germany and therefore have an increased risk of skin cancer. In this article the medical and technical prerequisites which have to be fulfilled for this new occupational disease in Germany are introduced.
    Der Hautarzt 03/2015; 66(3). DOI:10.1007/s00105-015-3587-z
  • [Show abstract] [Hide abstract]
    ABSTRACT: Condylomata acuminata (CA) are one of the most common sexually transmitted infections in the sexually active population. Due to the stigmatizing character of the disease and the high rate of relapse after therapy, CA may significantly affect patients' quality of life. Here, we report the case of successful treatment of multiple CA of the penis and scrotum in a 53-year-old man with ingenol mebutate gel.
    Der Hautarzt 03/2015; 66(4). DOI:10.1007/s00105-015-3593-1
  • [Show abstract] [Hide abstract]
    ABSTRACT: Am 09.11.2014 wurde feierlich des Falls der Mauer in Berlin vor 25 Jahren gedacht. Nach dem Mauerfall überstürzten sich damals die Ereignisse, und zum 03.10.1990 wurde die deutsche Einheit vollzogen.Auch im deutschen Berufskrankheitenrecht vollzieht sich in diesen Tagen - mit Verspätung - die deutsche Einheit.In der ehemaligen DDR (und für einen Übergangszeitraum bis 01.01.1992 im Gebiet der neuen Bundesländer) galt die „Liste der Berufskrankheiten gemäß Anlage zur BK-Verordnung der ehemaligen DDR vom 6. Mai 1981“. Diese sah unter Nr. 90 die Anerkennung von „Bösartigen Neubildungen der Haut und zur Krebsbildung neigenden Hautveränderungen“ vor, wobei unter dieser Ziffer nicht nur Hautkrebserkrankungen „durch Ruß, Rohparaffin, Teer, Anthrazen, Pech oder ähnliche Stoffe“ (entsprechend der in der Bundesrepublik geltenden Ziffer 5102 der Anlage 1 der Berufskrankheitenverordnung) anerkannt wurden, sondern auch Fälle von Hautkrebs durch berufliche Exposition mit UV-Licht.Im „Vertrag zwischen ...
    Der Hautarzt 03/2015; 66(3):152-153. DOI:10.1007/s00105-015-3588-y
  • [Show abstract] [Hide abstract]
    ABSTRACT: An 18-year-old female with palmoplantar keratoderma, hyperhidrosis, facial verruciform papillomatosis, coarse face, growth retardation and developmental delay presented to our outpatient clinic. A diagnosis of Costello syndrome was made, and genetic counseling and a molecular genetic analysis were initiated. By this means, a heterozygous missense mutation in exon 2 of the HRAS gene, designated c.34G > A (p.Gly12Ser), was detected, confirming the clinical diagnosis. Costello syndrome belongs to the group of clinically and genetically heterogeneous RASopathies with cutaneous symptoms. Collectively, the RASopathies are caused by mutations in different genes, which lead to dysregulation of the RAS/MAPK (mitogen-activated protein kinase) signaling pathway. This signaling route regulates the delicate balance between cell proliferation and differentiation, and plays an important role in embryogenesis and carcinogenesis. In the RASopathies with cutaneous symptoms, overlapping clinical findings may hamper making an accurate diagnosis. Therefore, a molecular genetic analysis may be useful, as in the patient described here.
    Der Hautarzt 02/2015; 66(4). DOI:10.1007/s00105-015-3592-2
  • [Show abstract] [Hide abstract]
    ABSTRACT: The BRAF inhibitor vemurafenib was approved in 2011 for the treatment of inoperable or metastatic melanoma. Vemurafenib therapy is associated with several side effects, such as arthralgia, secondary skin tumors or inflammatory rashes. In particular cutaneous toxicities represent a serious threat to patients' adherence. Here, we present the case of a successful drug desensitization in a patient that presented with a vemurafenib-induced rash. Lymphocyte activation tests failed to detect drug-specific T cells, suggesting that the development of the rash was based upon a nonallergic drug hypersensitivity reaction. A program of slow desensitization was initiated and subsequently, vemurafenib was tolerated at the full effective and recommended dosage.
    Der Hautarzt 02/2015; 66(4). DOI:10.1007/s00105-015-3590-4
  • [Show abstract] [Hide abstract]
    ABSTRACT: Many genodermatoses present early in life with a chronic and often debilitating, progressive course with multi-organ involvement and significant morbidity or even mortality. Therefore, timely determination of the correct diagnosis is highly needed to improve approaches of patient care. Considering the common geno- and phenotypic variability of genodermatoses, this is most accurately provided by means of molecular diagnostics. Characterization of disease-causing genetic aberrations along an algorithmic diagnostic approach further paves the way for strategies of targeted therapeutic intervention.
    Der Hautarzt 02/2015; 66(3). DOI:10.1007/s00105-014-3577-6
  • [Show abstract] [Hide abstract]
    ABSTRACT: Lupus erythematosus is a prototypic autoimmune disease that can be triggered in genetically predisposed individuals by environmental exposures. The disease is based on an uncontrolled activation of the immune system that recognizes self antigens and induces inflammatory disease flares. The multifactorial pathogenesis is based on a polygenic model of inheritance with multiple various susceptibility genes elevating the disease risk. Many of these polymorphisms have been recently identified by genome-wide association studies. Monogenic forms of lupus erythematosus are rare. The identification of their underlying pathogenesis is important for the recognition of main mechanistic pathways in lupus as demonstrated by the history of defects in the complement system. The monogenic, autosomal dominant inherited familial chilblain lupus is characterized by cold-induced infiltrates on acral locations occurring in early childhood. Molecular exploration of the disease pathogenesis revealed that autoimmunity and especially lupus erythematosus can be induced by defects in intracellular elimination of nucleic acids and the subsequent type I-IFN-dependent activation of the innate immune system. This mechanism extends the concept of lupus pathogenesis: both defects in the extra- and intracellular elimination of autoantigens can lead to activation of the innate and adaptive immune system.
    Der Hautarzt 02/2015; 66(2). DOI:10.1007/s00105-014-3570-0
  • [Show abstract] [Hide abstract]
    ABSTRACT: Eczema is a typical multifactorial disease which is based on an individual hereditary predisposition that becomes manifested by environmental and lifestyle factors. The heritability of eczema is estimated to be 70-80 %. The possibilities for deciphering inherited risk factors have significantly increased during recent years. As a result various genetic risk factors have been successfully identified and first insights into epigenetic changes have been obtained. With the growing knowledge about the constitutionally determined variability new disease models have been developed, which imply temporal and developmental interactions between genetic and environmental factors. Strategies for individualized prediction, prevention and therapy are conceivable.
    Der Hautarzt 02/2015; 66(2). DOI:10.1007/s00105-014-3565-x
  • [Show abstract] [Hide abstract]
    ABSTRACT: Currently the only approved drug available for the systemic therapy of atopic dermatitis is cyclosporine; however, based on current data from published studies, azathioprine, methotrexate, and mycophenolate mofetil or mycophenolic acid can be administered off-label. Some biologics on the market that have been approved for other indications (ustekinumab, rituximab, tocilizumab) have been successfully used in a few patients with atopic dermatitis. The world's first prospective controlled studies with the biologic human anti-IL4R antibody dupilumab for the indication "atopic dermatitis" were published in 2014. These motivated (1) to extend the studies to dupilumab and (2) to clinically test antagonization of other target molecules of TH2 polarized, atopic inflammation, e.g., IL-13, IL-31, IL-22, TSLP, and CRTH2. A number of clinical trials are currently recruiting in this area and will provide interesting new insights for future therapeutic approaches in atopic dermatitis.
    Der Hautarzt 02/2015; 66(2). DOI:10.1007/s00105-014-3575-8
  • Der Hautarzt 01/2015; 66(2). DOI:10.1007/s00105-014-3576-7
  • [Show abstract] [Hide abstract]
    ABSTRACT: Since dermal fillers were introduced in 1981, millions of patients have undergone wrinkle treatment with dermal fillers. Except for autologous fat, all fillers can act as potential foreign bodies, which have the potential ability to induce an immune reaction. Persisting material may induce activation of the immune system and finally granuloma formation. Frequency, histology, and clinical presentation of such foreign body reactions may vary depending on the filler used. This case describes a patient who received innumerable filler injections over the last two decades presenting with massive facial granulomas.
    Der Hautarzt 01/2015; DOI:10.1007/s00105-014-3578-5
  • [Show abstract] [Hide abstract]
    ABSTRACT: The mechanisms how the innate immune system detects microbes and mounts a rapid immune response have been more and more elucidated in the past years. Subsequently it has been shown that innate immunity also shapes adaptive immune responses and determines their quality that can be either inflammatory or tolerogenic. As atopic dermatitis is characterized by disturbances of innate and adaptive immune responses, colonization with pathogens and defects in skin barrier function, insight into mechanisms of innate immunity has helped to understand the vicious circle of ongoing skin inflammation seen in atopic dermatitis patients. Elucidating general mechanisms of the innate immune system and its functions in atopic dermatitis paves the way for developing new therapies. Especially the novel insights into the human microbiome and potential functional consequences make the innate immune system a very fundamental and promising target. As a result atopic dermatitis manifestations can be attenuated or even resolved. These currently developed strategies will be introduced in the current review.
    Der Hautarzt 01/2015; 66(2). DOI:10.1007/s00105-014-3563-z
  • [Show abstract] [Hide abstract]
    ABSTRACT: Patient satisfaction is an important factor for successful therapy. Many consensus reports have been published regarding correct treatment with botulinum toxin A (BTX-A). However, the focus of most of these publications has been on technical aspects and the important topic of patient satisfaction was often only one aspect among others. The Swiss Group of Esthetic Dermatology and Skincare (SGEDS) pursued these questions in a two-day consensus meeting. Patients of aesthetic dermatology are healthy and therefore place higher demands in contrast to ill patients of medical dermatology. This demands a great deal of the physician, the practice staff and the conditions in the practice to accommodate the special requirements of aesthetic clients. Informative consultation and patient education are of major importance; this also holds true for clinical performance and care before, during and after treatment with BTX-A. This publication aims at finding ways to gain greater patient satisfaction in daily practice.
    Der Hautarzt 01/2015; 66(2). DOI:10.1007/s00105-014-3572-y
  • [Show abstract] [Hide abstract]
    ABSTRACT: Methylisothiazolinone was permitted in 2004 as preservative in rinse-off and leave-on products by the European cosmetics directive. This led to a dramatic increase in contact eczemas induced by MI in the past few years. Here, we report a patient who developed a spreading contact eczema of the face, neck and proximal arms mimicking a photodermatosis. The reaction was caused by use of a facial ointment that only recently started to contain MI. Type IV-sensitization to MI was verified by patch testing.
    Der Hautarzt 01/2015; 66(6). DOI:10.1007/s00105-014-3557-x
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bazex's syndrome is a rare paraneoplasia that is usually associated with cancer. Characteristic for the disease are diffuse, psoriasis-like, acral erythema, distal hyperkeratosis and onychodystrophy. Differential diagnoses comprise psoriasis, eczema and tinea. We present the case of a 73-year-old man with acral hyperkeratosis, onychodystrophy, and diffuse palmar erythema. Gastric carcinoma was diagnosed by gastroscopy. After a gastrectomy was performed, regression of the skin lesions that the patient had been suffering from for more than 6 years was observed, confirming the diagnosis of Bazex's syndrome.
    Der Hautarzt 01/2015; 66(7). DOI:10.1007/s00105-014-3573-x
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recognizing the whole spectrum of comorbidities related to atopic dermatitis (AD) is prerequisite for adequate, patient-centered care. Based on systematic reviews (SRs) and published case-control studies, the current evidence on nonallergic comorbidities of AD is summarized. A comprehensive systematic literature search was performed in Medline and Embase (Search period: through 15 November 2014). In total, nine systematic reviews were included. Six reviews investigating the association between AD and cancer suggested a decreased risk of glioma, meningioma, and acute lymphoblastic leukemia in patients with current or previous AD. One SR reported a consistent positive association of AD with attention deficit hyperactivity disorder. In comparison, two SRs focusing on the relationship between AD and diabetes mellitus type 1 and multiple sclerosis showed that there is no evidence supporting an association. A further screening of individual observational studies concerning immunological and psychiatric diseases pointed out that AD seems to be a significant risk factor for Crohn's disease, affective, schizophrenic, and behavior disorders. Further longitudinal studies are needed to verify the existence of causal relationships. Interdisciplinary working groups are desirable to investigate explanations for genetic and physiologic mechanisms of described associations between AD and nonallergic comorbidities.
    Der Hautarzt 01/2015; 66(2). DOI:10.1007/s00105-014-3568-7
  • [Show abstract] [Hide abstract]
    ABSTRACT: Results of previous studies question the benefits of pulmonary surgery in patients with pulmonary metastases from malignant melanoma. A systematic literature search and analysis of articles published since 1 January 2000 was carried out to investigate the advantages of metastasectomy and alternative forms of therapy. Patients reached a median survival time of 17-40 months and 5-year survival rates between 18% and 39.4% after metastasectomy. Intrathoracic recurrence occurred in 30 % of patients but could be successfully treated with re-operations in some cases. Various monoclonal antibodies are currently available and achieve a median survival time of up to 17 months. Pulmonary metastasectomy is the treatment of choice in selected patients; however, in the future the benefits should be revalidated in comparison with pharmaceuticals of the current generation.
    Der Hautarzt 01/2015; 66(1). DOI:10.1007/s00105-014-3555-z